ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in over 10 different cities within the United States, Switzerland, England and Germany.

ACROBiosystems’ brands include FLAG, Star Staining, ViruStop, Aneuro, ComboX, GENPower, and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.

Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.

 Custom service catalogues : 

• SPR / BLI Analytical Service
• Quality Characterization Analytical Service
• Enzyme-Linked Immunosorbent Assay (ELISA) Service
• Meso Scale Discovery (MSD) Service
• Anti-Idiotypic Antibody Development Service
• Pseudovirus Services
• Custom GMP-grade Protein Services
• MHC Class I Complex Custom Service
• Recombinant Antibody Service
• Cell Line Customize Service